Potential new targets and drugs related to histone modifications in glioma treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential new targets and drugs related to histone modifications in glioma treatment

Published:2021-07 Issue: Volume:112 Page:104942
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wei Xiuhong,Xiao Bolian,Wang Liying,Zang Lanlan^ORCID,Che Fengyuan

Funder

Shandong Province Natural Science Foundation

State Administration of Traditional Chinese Medicine of The Peoples Republic of China

China Postdoctoral Science Foundation

Key Technology Research and Development Program of Shandong

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference150 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016;Ostrom;Neuro Oncol.,2019

2. Advances in targeting the epidermal growth factor receptor pathway by synthetic products and its regulation by epigenetic modulators as a therapy for glioblastoma;Nadeem Abbas;Cells,2019

3. An updated nationwide epidemiology of primary brain tumors in Republic of Korea, 2013;Dho;Brain Tumor Res. Treat.,2017

4. The 2016 world health organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

5. Potential epigenetic-based therapeutic targets for glioma;Zang;Front. Mol. Neurosci.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma;The Kaohsiung Journal of Medical Sciences;2024-03-14

2. IQGAP3 promotes the progression of glioma as an immune and prognostic marker;Oncology Research;2024

3. FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response;Aging;2023-06-10

4. Down-regulation of CX43 expression by miR-1 inhibits the proliferation and invasion of glioma cells;Translational Cancer Research;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3